Lake Hills Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$976K Buy
13,936
+4,590
+49% +$237K 0.44% 39
2026
Q1
$475K Buy
+9,346
New +$436K 0.27% 36

Other funds holding MRNA

Lake Hills Wealth Management's MRNA Position: Q2 2026 in Review

Lake Hills Wealth Management increased its Moderna (MRNA) stake by 49% in Q2 2026, buying an estimated $237K and bringing the position to 13,936 shares worth $976K. The position accounts for 0.44% of the portfolio, ranked #39.

Lake Hills Wealth Management first reported a position in MRNA in Q1 2026 and has held it in 2 quarters since. 259 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Lake Hills Wealth Management held 13,936 shares of Moderna worth $976K as of Q2 2026.
  • Lake Hills Wealth Management bought 4,590 Moderna shares in Q2 2026, an estimated $237K.
  • Moderna made up 0.44% of Lake Hills Wealth Management's portfolio in Q2 2026, its #39 holding.
  • Lake Hills Wealth Management first reported a position in Moderna in Q1 2026 and has held it in 2 quarters since.
  • 259 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Lake Hills Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.